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22.1  Pregnancy Complications at the Global Level
According to the data provided by the Global Health Observatory of the WHO, 
every day in 2015, about 830 women died due to complications of pregnancy and 
child birth. Almost all of these deaths occurred in low-resource settings and are 
related to pregnancy complications that are inadequately managed because of a lack 
of access to emergency health care. More precisely, of the 830 daily maternal deaths, 
550 occurred in sub-Saharan Africa (SSA) and 180 in Southern Asia (SA), com-
pared to 5 in wealthy nations [1]. In particular the maternal mortality ratios (MMRs) 
of Sweden, the United Kingdom, and the United States are 4, 12, and 21, respec-
tively, whereas those of Chad, Nigeria, and Congo are 1100, 630, and 540 per 
100,000 live births, respectively. The primary causes of death are haemorrhage, 
hypertension, infections, and indirect causes, mostly due to interaction between pre- 
existing medical conditions and pregnancy [2]. These high maternal and associated 
neonatal mortality rates persist despite considerable efforts from the World Health 
Organization, governments, development partners, and others [3]. Furthermore it is 
now evident that disparities in pregnancy and child birth are also present among 
minority groups living in Europe. In wealthy countries, women from minority racial 
groups have a higher prevalence of a wide range of adverse pregnancy outcomes, 
including miscarriage [4], stillbirth [5], pre-eclampsia (PE) [6–8], gestational 
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hypertension (GH) [9], gestational diabetes mellitus (GDM) [9–11], preterm deliv-
ery (PTD) [9, 12], delivery of small-for-gestational-age (SGA) [13, 14] or large-for- 
gestational-age (LGA) [15, 16] neonates, and elective or emergency Caesarean 
section (CS) [17]. Apart from the obvious, cultural, and socioeconomic factors and 
different priorities in health care, additional biological reasons might be responsible 
for pre-eclampsia syndromes being such a prominent feature of African obstetrics. 
Hypertension developing in the second half of pregnancy is subdivided according to 
the presence or absence of co-existing significant proteinuria into pre-eclampsia and 
gestational hypertension. These two aspects are therefore important for ethnic 
minorities living in wealthy countries.
22.2  Pre-eclampsia in Ethnic Minorities
22.2.1  Pre-eclampsia
Pre-eclampsia, defined by the International Society for the Study of Hypertension in 
Pregnancy as blood pressure ≥  140/90 mmHg and 24-h proteinuria ≥0.3 g, is a 
multisystem disorder characterized by abnormal vascular response to placentation 
[18]. The syndrome is characterized by proteinuria and hypertension in a previously 
normotensive woman after gestational week 20 and occurs with a 2–8% incidence 
of all pregnancies [19]. Pre-eclampsia is a leading cause of maternal morbidity and 
mortality globally, accounting for an estimated 50,000 maternal deaths annually 
[19]. An important determinant of pre-eclampsia is failure of placentation, particu-
larly the physiological transformation of spiral arteries, which leads to a stressed, 
underperfused placenta [20]. Pre-eclampsia is a recognized clinical entity character-
ized by new onset of hypertension and proteinuria after 20 weeks’ gestation [19, 21, 
22]. In SSA the distinction between true pre-eclampsia and pregnancy-induced 
hypertension is sometimes difficult because proteinuria may not be adequately mea-
sured. A further problem is a lack of information on pre-existing hypertension 
because presentation to the clinic is often late. Data on pre-eclampsia in African 
Americans (AA) and immigrants from Africa to other high-income countries as 
compared with other ethnic groups are now available.
In the United States, Black ethnicity is cited as a risk factor for pre-eclampsia 
[23]. Of four million births recorded in the National Vital Statistics Report, 
pregnancy- associated hypertension was more common in AA (5.0%) and least fre-
quent in Hispanics (2.9%), and AA women had the highest risk for all the different 
types of pre-eclampsia when compared with European American women [24]. In a 
10-year longitudinal population-based study aimed at investigating ethnic disparity 
in hypertensive disorders of pregnancy in New York State, AA women had OR 1.67 
(1.64 to 1.71) for pre-eclampsia vs. White women [25]. Poor socioeconomic status 
with lower incomes and level of education, lack of medical insurance, poor utiliza-
tion of preconception and antenatal services, stress, discrimination, and residential 
segregation were often reported as possible explanations. However, many of the 
socioeconomic factors that may contribute to poor obstetric outcomes also apply to 
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the Hispanic population in the United States, yet several studies have noted that pre- 
eclampsia, low birth weight, and stillbirth are similar or even better than for White 
women, the Hispanic paradox [7, 26].
Obstetric outcomes for recent African immigrants in Europe are informative, 
particularly because these births often take place in countries with good records and 
universal health-care systems [8]. In the Netherlands, the highest risk for eclampsia 
and pre-eclampsia was from women from SSA [27, 28]. Cape Verdean and Antillean 
women were also at higher risk of pre-eclampsia in a report from Rotterdam, the 
Netherlands [29].
In a large retrospective study in women with singleton pregnancies attending 
their first routine hospital visit, 80,000 pregnancies that included women of 
European and Asian ancestry were considered [30]. In Afro-Caribbean women, 
compared with Caucasians, there was a higher prevalence of miscarriage, stillbirth, 
pre-eclampsia, gestational hypertension, small-for-gestational age, spontaneous and 
iatrogenic preterm delivery, and emergency Caesarean section [30]. South Asian 
racial origin was associated with increased risk for gestational diabetes mellitus, 
pre-eclampsia, small-for-gestational age, iatrogenic preterm delivery, and Caesarean 
section, and East Asian race had increased risk for gestational diabetes mellitus and 
small-for-gestational age [30]. Similarly, in a prospective screening study for hyper-
tensive disorders in women attending for their routine first hospital visit in preg-
nancy performed in the United Kingdom, Black women were found at increased 
risk of early pre-eclampsia, both Black and South Asian women being at increased 
risk for late pre-eclampsia [31]. Predictors of early pre-eclampsia were Black race, 
chronic hypertension, prior PE, and use of ovulation drugs [31]. Late pre-eclampsia 
was more common in Black, Indian, and Pakistani women [31]. After a woman has 
had pre-eclampsia in her first pregnancy, the risk of recurrence is increased, with a 
relative risk of 15.0 in an authoritative Norwegian study of more than two million 
women [32]. Other reports support these findings [8].
22.2.2  Genetics of Pre-eclampsia
A genetic component to pre-eclampsia has long been suspected on the basis of a 
familial recurrence of the syndrome. Daughters of women with pre-eclampsia have 
more than twice the risk of developing the disease themselves, and sisters of affected 
women, even if not born from a pre-eclamptic pregnancy, are also at increased risk 
[33, 34]. Although environmental factors, particularly influences acting in utero, are 
important, some of the risk is likely to be genetic. Using ancestry informative mark-
ers, a case-control study of pre-eclampsia in Latinas, a group with admixture from 
European, African, and native Americans, showed that African ancestry was associ-
ated with pre-eclampsia [35]. Many reports indicate also a paternal contribution to 
the risk [36].
Some components of the innate and adaptive immune system may participate in 
the physiopathology of pre-eclampsia [37]. Although it is believed that placental 
hypoxia plays a relevant role in pre-eclampsia, recent studies suggest that the 
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presence of hypoxic conditions may not be the key feature in all pre-eclamptic 
patients. The wall of the uterus is the territorial boundary between two genetically 
different individuals: the mother and the foetus. The uterine mucosal immune sys-
tem appears to define this maternal/placental boundary. The decidua must control 
placentation, because in its absence, the trophoblast infiltrates to a dangerous extent, 
causing the condition of placenta accreta [38]. The decidua contains an abundant 
population of specialized natural killer (NK) cells. Placental NK cells, designated as 
uNK cells, play an important role in the acceptance and rejection of the foetus, as 
they are in direct contact with the trophoblasts [39]. uNK cells express killer-cell 
immunoglobulin-like receptors (KIRs) that recognize trophoblast HLA-C ligands 
[40]. Both KIR and HLA-C are genetically variable, resulting in many possible 
combinations of maternal KIR and foetal HLA-C ligands [41]. The KIR region is 
defined by two groups of haplotype: A and B. The KIR A haplotype has seven KIR 
genes, all encoding inhibitory receptors apart from KIR2DS4. In contrast, the KIR 
B haplotype contains a variable number of additional KIR, most of which encode 
activating receptors [42]. All HLA-C allotypes are KIR ligands and can be divided 
into two groups (carrying either C1 or C2 epitopes) that are distinguished by a 
dimorphism at position 80 and recognized by different KIRs [43]. A variety of dis-
eases and clinical conditions has been associated with combinations of HLA-C and 
KIR genes. Case-control studies of pre-eclampsia performed both in pregnant 
European women [40, 44] and in sub-Saharan African women [45] showed that, 
when the foetus carries a C2 epitope, maternal KIR AA genotypes are risk factors 
for pre-eclampsia in both European and sub-Saharan African pregnant women, 
whereas different KIR B regions confer risk protection from pre-eclampsia in sub- 
Saharan African [45] and in European women [40, 44]. The KIR2DS1 gene of 
maternal KIR B haplotypes is protective in European women [40, 44]. The KIR2DS5 
and KIR2DL1 genes confer risk and protection to pregnant SSA women [45].
22.2.3  Implications for Birth Weight
Functionally, the risky combination could result in very strong inhibition of uterine 
NK cells. Triggering of uterine NK cells by HLA-C2 target cells in  vitro from 
women who have a protective KIR B haplotype (in which the activating KIR for 
HLA-C2, KIR2DS1, is located) results in secretion of cytokines and chemokines 
that may facilitate trophoblast invasion and vascular transformation limiting the 
highly invasive placenta while at the same time ensuring the foetus receives suffi-
cient nourishment for normal development through remodelling of the spiral arter-
ies [8]. A failure of the physiological transformation of uterine arteries is a common 
feature of all the great obstetric syndromes, and this results in a reduced placental 
supply of oxygen and nutrients, lower birth weights, and the risk of preterm labour 
and superimposed pre-eclampsia. However, at the same time, maternal and neonatal 
mortality is not only high under circumstances of reduced foetal nutrition but also 
when babies are too large for the pelvis. The optimal survival of babies weighing 
between 2.5 and 3.5 kg seems to be a universal feature of human populations. If 
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babies become too large, the risk of prolonged obstructed labour, birth asphyxia, 
and postpartum haemorrhage is increased. Furthermore, these outcomes are much 
more common in African women with associated features of pregnancy that favour 
smaller babies: earlier birth (the gestational age is reduced to 38 weeks), the head 
engages late into the pelvis, and the baby matures earlier than in non-Africans [8]. 
The small neonatal size in ethnic minority groups is also, at least in part, due to 
persistent maternal constraints on foetal growth and can probably be regarded as 
mismatched when exposed to the current obesogenic environment. Thus, there is 
high mortality in mother and babies not only from pre-eclampsia (associated with 
low birth weight and still birth) but also at the other end of the normal birth weight 
spectrum. Both mothers and their babies benefit if the latter have intermediate birth 
weights and the two extremes of very low and high birth weight are selected against. 
The balance between these two extremes is partially determined at placentation, 
when uNK allows trophoblast cells to access sufficient maternal oxygen and nutri-
ents without starving the baby (defective trophoblast invasion) or risking uterine 
rupture (excessive trophoblast invasion). In an African population, because of the 
greater risk of cephalopelvic disproportion, there is even greater selection for 
reduced foetal size with associated pre-eclampsia; this effect is consistent with the 
higher frequency of maternal KIR AA/paternal C2 combinations in SSA.  In 
Europeans, opposing KIR/HLA-C combinations are associated with the extremes of 
birth weight: a paternal C2 epitope is associated with both extremes, but in pre- 
eclampsia and low birth weight (less than fifth centile), the risk is with maternal 
KIR AA genotypes, whereas in high birth weight, the association is with maternal 
KIR2DS1. Thus, there is a balance between the KIR A and KIR B haplotypes in 
both populations, but they differ in the regions of the KIR B haplotype that correlate 
with protection from pre-eclampsia. tB regions and KIR2DS1 are infrequent in 
Africans compared with Europeans, but the opposite is true for cB regions contain-
ing KIR2DS5. During the out-of-Africa migrations, it is possible that only individu-
als having tB with KIR2DS1 moved away from SSA. The higher Caesarean section 
rates seen in high-income countries in women of African ancestry may reflect not 
just delivery of women with pre-eclampsia but also an increased frequency of 
obstructed labour [46]. Furthermore, shoulder dystocia has also been reported to 
occur more commonly in African American women [47].
Thus, different KIR B regions protect sub-Saharan Africans and Europeans from 
pre-eclampsia, whereas in both populations, the KIR AA genotype is a risk factor 
for the syndrome. These results emphasize the importance of undertaking genetic 
studies of pregnancy disorders in African populations with the potential to provide 
biological insights not available from studies restricted to European populations.
22.3  Gestational Diabetes Mellitus in Ethnic Minorities
One consistent finding from studies from the Netherlands [48], Switzerland [49], 
and Norway [50] was that women originating from African and Middle Eastern 
countries tended to enter their pregnancies with higher BMI levels than the majority 
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population in each country. All studies found, on the other hand, that pregnant 
women of South and East Asian descent overall were leaner than the European 
population. For instance, Asian/Asian British and Chinese/other had significantly 
higher OR for lean (BMI < 18.5) vs. ideal weight compared with White British 
women [51]. However, these figures need to be interpreted considering studies 
showing substantial differences in the amount of body fat relative to BMI across 
ethnic groups, especially in Asians [52, 53]. South Asians appear to be more insulin 
resistant than Europeans for the same level of BMI [54].
Pregnancy can be considered as a diabetogenic and inflammatory state due to the 
higher levels of maternal insulin resistance, hyperlipidaemia, and fat deposition. 
These normal alterations are aggravated by maternal adiposity. The insulin resistance 
in pregnancy increases about 50–60% during pregnancy, irrespective of the prepreg-
nant level. Thus, overweight and obese women start their pregnancy more insulin 
resistant compared with normal weight women and become highly insulin resistant 
in the second half of their pregnancy. This is also the case for pregnant women from 
East and South Asia, as they are found to be more insulin resistant compared with 
Western Europeans for the same level of BMI. Pancreatic B cells must compensate 
for the pregnancy-induced insulin resistance with increased insulin secretion. If not, 
hyperglycaemia may occur. South Asian women are reported to be less able to 
increase their B-cell function mutual to the pregnancy-induced insulin resistance 
compared with Western Europeans [55]. Reduced B-cell insulin response, in the set-
ting of insulin resistance, is also seen among Asians outside pregnancy [56].
Gestational diabetes mellitus is defined as any degree of glucose intolerance with 
onset or first recognition during pregnancy [57, 58]. The different methodologies, 
diagnostic criteria, and screening practices make comparison of prevalence figures 
between populations a challenge [59, 60]. In line with the trends for obesity and 
T2DM, increasing rates of GDM and undiagnosed T2DM in pregnant women 
attending antenatal care are observed in most parts of the world. A 2–3 higher OR 
for GDM was observed in women of South Asian origin [30, 50, 61–63]. The group-
ing of the ethnic minority population varies between studies, but also Black African 
[61], East Asian and Afro-Caribbean [30], and Middle Eastern [50] women had 
significantly higher OR for GDM.
The increasing trend for GDM globally, and the relatively higher susceptibility 
of many ethnic minority women in Europe today, is worrisome. GDM may reflect 
either a pre-existing, an undiagnosed T2DM, or a pregnancy-induced glucose- 
intolerant state with a high risk of future T2DM [64]. T2DM may be prevented or 
postponed in women after a pregnancy complicated by (GDM) and most clinical 
guidelines recommend a sustained screening program [65]. The time when the preg-
nancy GDM developed, obesity, insulin needs influence the gradual reduction in 
B-cell function and progression into T2DM [66]. Ethnicity is another parameter 
influencing the progression of the disease though the relation is complex and seems 
to differ between studies [67, 68]. Recurrence rates of GDM in subsequent pregnan-
cies vary between 30 and 84%, with higher rates in minority groups compared with 
White populations and among those who do not develop GDM in a second preg-
nancy, had a reduced risk of T2DM [69].
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A GDM pregnancy implies a substantially increased risk of future T2DM, 
although ethnic differences in conversion rates may exist. GDM may also imply a 
slight predisposition to later CVD. Regarding the neonates of women descending 
from Asian and African countries, the birth weights are generally lower than in the 
majority population. The small neonatal size in ethnic minority groups is most 
likely, at least in part, due to persistent maternal constraints on foetal growth and 
can probably be regarded as mismatched when exposed to the current obesogenic 
environment. Evidence is mounting that low birth weight increases the risk of later 
obesity, T2DM, and CVD. Furthermore, neonates exposed to maternal obesity and 
GDM may carry an increased risk of the same conditions linked to foetal 
overgrowth.
New public health initiatives need to focus more on early life interventions as 
interventions in adulthood have shown limited results. As breastfeeding may be 
associated with a decreased risk of obesity and adult disease both for the mother and 
baby, current efforts to promote breastfeeding should be strengthened, not least for 
ethnic minority groups.
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